Literature DB >> 15798491

Use of diet and probiotic therapy in the irritable bowel syndrome: analysis of the literature.

Martin H Floch1.   

Abstract

GOAL: The goal of this report is to review the use of dietary intake and probiotics in patients with irritable bowel syndrome (IBS) in published reports.
BACKGROUND: Dietary factors can be important in inducing symptoms that occur in patients with the IBS. Dietary intolerances, dietary allergies, specific food metabolites, and regular diet contents all may act as triggers and aggravate the symptoms of IBS; but when any of these mechanisms can be proven to cause the symptoms, then their elimination results in the resolution of that patient's IBS.
METHODS: Our previous review was updated. In addition, a careful Medline search was made for the years from 1975 to 2004 to evaluate human research reports on diet and probiotics in the IBS. Forty-six manuscripts were reviewed on diet and six were available on probiotic use in IBS. The most common dietary factor evaluated in the literature was bran, and the most common probiotic used was Lactobacillus plantarum.
CONCLUSIONS: Although investigations have shown that bran may be helpful in some patients, a complete review of the literature does not reveal conclusive evidence that diet therapy is effective in IBS. From the limited reports on probiotics, there appears to be a trend to decreasing symptoms. It is clear that much more prospective research is needed to study both dietary factors and probiotics in these areas.

Entities:  

Mesh:

Year:  2005        PMID: 15798491     DOI: 10.1097/01.mcg.0000156104.67505.5b

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  10 in total

1.  So-eum type as an independent risk factor for irritable bowel syndrome: a population-based study in Korea.

Authors:  Seung Ku Lee; Dae Wui Yoon; Hyeryeon Yi; Si Woo Lee; Jong Yeol Kim; Jin Kwan Kim; Jeong Hwa Hong; Chol Shin
Journal:  J Altern Complement Med       Date:  2014-08-22       Impact factor: 2.579

2.  Effect of Bifidobacterium infantis 35624 (Align) on the Lactulose Breath Test for Small Intestinal Bacterial Overgrowth.

Authors:  Krishma Kumar; Mohammed Saadi; Frederick V Ramsey; Ron Schey; Henry P Parkman
Journal:  Dig Dis Sci       Date:  2018-02-03       Impact factor: 3.199

Review 3.  Post-infectious irritable bowel syndrome.

Authors:  Andrew W Dupont
Journal:  Curr Gastroenterol Rep       Date:  2007-10

4.  A very low-carbohydrate diet improves symptoms and quality of life in diarrhea-predominant irritable bowel syndrome.

Authors:  Gregory L Austin; Christine B Dalton; Yuming Hu; Carolyn B Morris; Jane Hankins; Stephan R Weinland; Eric C Westman; William S Yancy; Douglas A Drossman
Journal:  Clin Gastroenterol Hepatol       Date:  2009-03-10       Impact factor: 11.382

5.  Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: a randomized, double-blind study.

Authors:  Michel Dapoigny; Thierry Piche; Philippe Ducrotte; Bernard Lunaud; Jean-Michel Cardot; Annick Bernalier-Donadille
Journal:  World J Gastroenterol       Date:  2012-05-07       Impact factor: 5.742

Review 6.  Human gut microbiota: the links with dementia development.

Authors:  Rashad Alkasir; Jing Li; Xudong Li; Miao Jin; Baoli Zhu
Journal:  Protein Cell       Date:  2016-11-19       Impact factor: 14.870

7.  Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS.

Authors:  Paola Brun; Melania Scarpa; Chiara Marchiori; Gloria Sarasin; Valentina Caputi; Andrea Porzionato; Maria Cecilia Giron; Giorgio Palù; Ignazio Castagliuolo
Journal:  PLoS One       Date:  2017-07-21       Impact factor: 3.240

8.  Effect of Bacillus subtilis, Enterococcus faecium, and Enterococcus faecalis supernatants on serotonin transporter expression in cells and tissues.

Authors:  Yi-Ming Chen; Ying Li; Xin Wang; Ze-Lan Wang; Jun-Jie Hou; Shuai Su; Wei-Long Zhong; Xin Xu; Jie Zhang; Bang-Mao Wang; Yu-Ming Wang
Journal:  World J Gastroenterol       Date:  2022-02-07       Impact factor: 5.742

9.  A randomised controlled trial of a probiotic 'functional food' in the management of irritable bowel syndrome.

Authors:  Lesley M Roberts; Deborah McCahon; Roger Holder; Sue Wilson; F D Richard Hobbs
Journal:  BMC Gastroenterol       Date:  2013-03-07       Impact factor: 3.067

Review 10.  A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome.

Authors:  Nourieh Hoveyda; Carl Heneghan; Kamal R Mahtani; Rafael Perera; Nia Roberts; Paul Glasziou
Journal:  BMC Gastroenterol       Date:  2009-02-16       Impact factor: 3.067

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.